Alpha-2 macroglobulin, hyaluronic acid (HA), tissue inhibitor of metalloproteinase 1, and the amino-terminal peptide of procollagen III are included in a validated serum panel to distinguish mild to moderate fibrosis from advanced fibrosis in adult NAFLD patients [35]. The gene discussed is A2M; the disease is metabolic dysfunction-associated steatotic liver disease.